Well either way.. it's a catalyst ill be waiting on before entering.
simply due to my tfsa account.. needing a qualified canadian stock..
Plus i think the nature of Ehave is requiring the clinical trial data in order to populate the pages on the 'book of marijuana' to turn it into penacillin so doctors can prescribe post Oct 17th to para-phrase the ceo..
This one is on the 'wait and see' for me.. I love the institutional connections UHN, PEAR and sub-Aurora-Medreleaf business connections.
all that stuff..
I think right now the tech is a bit ahead of the 'legal and medical data framework.
Could be wrong.
Anyone care to list some clincial trials worth reading on MMarijuana